Close menu




Comments

Photo credits: pixabay.com

Commented by Juliane Zielonka on August 18th, 2022 | 13:50 CEST

Apple, Tocvan Ventures, Valneva - More returns through innovation or risk hedging?

  • Mining
  • Gold
  • Innovations
  • Pharma

Innovations are hailed as market drivers. The more innovative a company is, the more likely it is to stay ahead of the competition. But this requires loyal customers who also support these innovations. And Apple has just such a customer base, setting a good example that loyalty must be rewarded for innovation. In contrast, pharmaceutical company Valneva has the challenge of exposure to different development cycles in the healthcare market. If only because of the duration of clinical studies, which rightly have to go well before a new product comes onto the market. This time, nature lovers could benefit. Those who find all this too volatile and unpredictable should once again turn to commodities as a hedge. With Tocvan Ventures, a candidate is in the running that looks very closely at optimizing the costs of its operations - to the benefit of investors.

Read

Commented by Nico Popp on August 18th, 2022 | 13:07 CEST

An explosive mixture is emerging here: Airbus, Defense Metals, NIO

  • RareEarths
  • Defense
  • Electromobility

Hydrogen, electromobility, armaments - they still exist, the trends that bring investors double-digit returns within a very short time. But where is the line between a bull market and a bear market rally? Instead of betting on yesterday's high flyers, investors can invest in stocks where scarcity and the spirit of the times coincide. We outline three possible investments and get to the bottom of the related stocks.

Read

Commented by André Will-Laudien on August 18th, 2022 | 12:57 CEST

Watch out! BASF, Varta, Barsele Minerals and Nordex - These shares are mastering the energy crisis

  • Mining
  • Gold
  • GreenTech
  • Technology

Renewable energies are one of the most important factors when it comes to a green lifestyle. After all, modern man wants to remain mobile, even if fossil resources no longer harmonize with the concepts of the future. For years, there were extensive studies that primary energy sources such as oil and gas, which have been locked up for millions of years, should not be released into the atmosphere. The scientists were not heard for a long time, and now after substantial climatic changes, attempts are being made to turn the tide using all means at their disposal. Too late? Perhaps, but many companies are positioning themselves correctly now. We keep an eye on these values.

Read

Commented by Stefan Feulner on August 18th, 2022 | 11:28 CEST

New opportunities with BYD, MAS Gold and BASF

  • Mining
  • Gold
  • Electromobility

If you do not have the shares when they fall, you will not have them when they rise! As stock market legend André Kostolany noted, it is extremely difficult to hit the exact low point to enter. By waiting, however, most investors miss the subsequent price increases. The current price weakness could represent the final wave down for the precious metals of gold and silver. Subsequently, quite a few chartists expect a long-lasting upward movement. From this point of view, putting the first foot in the door on selected gold mining stocks is probably not the worst decision.

Read

Commented by Mario Hose on August 18th, 2022 | 10:28 CEST

Defence Therapeutics CEO Sébastien Plouffe on the next steps in the battle against cancer

  • Expert
  • DefenceTherapeutics
  • Cancer

A publicly traded biotechnology business called Defence Therapeutics is developing new vaccines and antibody-drug conjugates (ADC) products on its own proprietary platform. The ACCUM technology, which enables precise delivery of vaccine antigens or ADCs in their intact form to target cells, forms the basis of Defence Therapeutics' platform. As a result, catastrophic illnesses like cancer and infectious diseases can be combated with greater efficacy and potency. CEO Sébastien Plouffe gives us background on the company's latest development in the battle against cancer.

Read

Commented by Fabian Lorenz on August 18th, 2022 | 10:21 CEST

Sell Nel ASA? Buy HelloFresh and Aspermont?

  • Technology
  • Media
  • Fintech

Despite individual setbacks, the mood on the stock market is currently good and the summer rally is underway. Alongside shares from the technology sector, hydrogen stocks such as Plug Power and Nel ASA are currently among the high flyers. However, JPMorgan is interfering. The analysts rate the hydrogen specialist as "Underweight" and thus advise selling. They believe the share price could drop by a significant double-digit percentage. In contrast, two analysts have commented positively on HelloFresh. Berenberg even sees a doubling potential. There are also praising words for Aspermont. The debt-free Company is growing, the new fintech platform is exciting, and the valuation is very low compared to the peer group.

Read

Commented by Nico Popp on August 17th, 2022 | 13:45 CEST

E-cars? This is what matters now! Mercedes-Benz Group, Altech Advanced Materials, Varta

  • Electromobility
  • E-Cars
  • Sustainability

Higher, faster, further: That is the claim of the automotive industry for new e-car models. In fact, a lot has happened in recent years. From e-cars made in France, which at best managed around 200km, to sedans that now travel 1,000km, the development is great. Nevertheless, the comparison between small cars, sedans or SUVs is limp. Reason enough to take a closer look at what really makes e-cars better, using three listed companies as examples.

Read

Commented by André Will-Laudien on August 17th, 2022 | 13:10 CEST

Hydrogen presses the gas pedal: Plug Power, First Hydrogen, Nel, Ballard Power - 100% rally is real!

  • Hydrogen

Prime Minister Justin Trudeau and German Chancellor Olaf Scholz will sign an agreement to jointly support the production of hydrogen fuel in Canada for export to Germany, the German government announced Friday. The head of government, accompanied by Economics Minister Robert Habeck, will travel to Canada on August 21-23 to establish this important agreement on climate protection. The processes are still costly and only conditionally competitive, but if fossil fuels remain permanently expensive, it will be exciting. Who is ahead in H2 shares?

Read

Commented by Fabian Lorenz on August 17th, 2022 | 13:05 CEST

Over 200% share price potential? Analysts on BioNTech, BASF and Saturn Oil + Gas

  • Mining
  • Oil
  • Biotechnology

The stock markets are friendly this week and the summer rally continues. Analysts still see room for improvement in the BioNTech share. The German biotech leader could be in for a golden autumn. Its product pipeline is promising. High energy prices and a looming gas shock in winter are causing trouble for the share of BASF. Analysts are also divided: "outperform" or "sell"? At Saturn Oil & Gas, free cash flow could almost reach the level of current market capitalization in the coming year. Therefore, analysts predict a revaluation potential and a share price potential of more than 200%. After all, investor legend Warren Buffett also backs oil producers.

Read

Commented by Armin Schulz on August 17th, 2022 | 11:58 CEST

Daimler Truck, dynaCERT, Nikola - Which transportation stocks are taking off?

  • Electromobility
  • Hydrogen

The transportation industry faces many challenges. These were addressed on July 15 at the 15th Truck Symposium, hosted at Nürburgring. Here, 110 experts discussed staff shortages, lack of parking spaces and new drive concepts. The latter is still the subject of controversial debate. Are fully electric transport vehicles the future, or will the hydrogen fuel cell prevail? The fact is that the transport industry must significantly reduce its emissions by 2030. Today, we look at three companies that offer solutions for lower CO2 emissions.

Read